OGLUO

This brand name is authorized in Croatia, Estonia, Ireland, Lithuania, Poland.

Active ingredients

The drug OGLUO contains one active pharmaceutical ingredient (API):

1	Glucagon UNII 1H87NVF4DB - GLUCAGON HYDROCHLORIDE
	Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.
	Read more about Glucagon

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OGLUO Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H04AA01	Glucagon	H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1841813, 1841824, 1841835, 1841846, 1841857, 1841868, 1841879, 1841880
LT	Valstybinė vaistų kontrolės tarnyba	1092063, 1092064, 1092065, 1092066, 1092067, 1092068, 1092069, 1092070
PL	Rejestru Produktów Leczniczych	100448499, 100448507, 100448520, 100448536